SUNRISE, Fla., Feb. 6, 2009 (GLOBE NEWSWIRE) -- Bioheart, Inc. (Nasdaq:BHRT), a company committed to delivering intelligent devices and biologics that help monitor, diagnose and treat heart failure and cardiovascular diseases, announced today that Howard J. Leonhardt, chief executive officer and chairman, will provide an update of corporate activities at the 11th Annual BIO CEO & Investor Conference on Monday, February 9, 2009, at 11:00 a.m. Eastern time. The presentation is being held at the Waldorf-Astoria in New York City.
